null Overcoming the greatest obstacle to curing HIV

RI-MUHC researcher participated in the groundbreaking study published in Nature

Dr. Jean-Pierre Routy is a member of the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the MUHC
Dr. Jean-Pierre Routy is a member of the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the MUHC

Feb. 12, 2020

Source: MUHC. In a groundbreaking study published in Nature, an American team of researchers from the University of North Carolina at Chapel Hill and Emory University in Atlanta achieved a long-sought-after goal: to push the human immunodeficiency virus (HIV) out of dormancy.

“We are halfway there,” says Dr. Jean-Pierre Routy, Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), Clinical Director of the Chronic Viral Illness Service at the MUHC, and the only Canadian to have participated in the study. “The HIV virus hides in CD4+ T cells in a latent form that is invisible to immune cells. We ‘pulled’ it out of the human gene in a way that was never achieved before, so that it could be recognized and attacked by the immune system. And we succeeded in doing this both in mice tolerating human blood —‘humanized’ mice—and in SIV-infected monkeys, which gives us great hopes for the future.”

Currently, HIV-positive people are on antiretroviral therapy (ART) that can suppress HIV to undetectable levels in the blood, but the virus persists throughout the body in infected CD4+ T cells. The immune system cannot recognize these infected cells, and no therapy can eliminate them.

“When ART is stopped, the viral load rebounds rapidly in the blood. This is why HIV-positive people have to take ART continuously,” explains Dr. Routy.

Revealing the hidden virus

The team of researchers used a compound called AZD5582 to activate latently infected CD4+ T cells via a non-canonical NFkB inflammatory pathway, and they did so at impressive levels in blood and in many different tissues, with little or no toxicity. Their results pave the way for the development of a therapeutic target as the virus can now be seen under antiretroviral therapy.

“The number one challenge for a cure was to expose the latent viral reservoir,” says Dr. Routy. “Now that we achieved that, we are closer to tackling challenge number two, which is to eliminate it as a visible foe. And there is promising research happening on that front, too.”

To learn more:

Researchers reverse HIV latency, important scientific step toward cure
University of North Carolina Health Care press release

NIH-supported scientists reverse HIV and SIV latency in two animal models
NIH press release

Reactivation of latent HIV moves shock-and-kill treatments forward
Nature news article